Navigation Links
Ambulatory Services of America, Inc. Announces the Acquisition of Dialysis Operations in St. Louis, Missouri
Date:7/2/2008

NASHVILLE, Tenn., July 2 /PRNewswire/ -- Ambulatory Services of America, Inc. announced the acquisition of three dialysis centers in the St. Louis, Missouri area from Affiliated Hospitals Dialysis Center. Affiliated Hospitals Dialysis Center is a joint venture between St. Luke's Episcopal-Presbyterian Hospitals and St. John's Mercy Health System. Prior to the acquisition, the program provided services to more than 300 patients through the three outpatient dialysis centers and a home dialysis program.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO)

Ambulatory Services of America's dialysis subsidiary, Renal Services of America, will operate the acquired program and will offer state-of-the-art hemodialysis treatment services in the St. Louis centers. Paul Mennes, M.D. will serve as regional medical director for RSA's dialysis operations in St. Louis, and Drs. Annibal Melo, Thomas Pohlman, Robert Cuddihee, Mark Ravenscraft and Robyn Jacobs will serve as medical directors of the acquired facilities and home program.

Dr. Mennes said, "We are glad to join forces with a vibrant and growing company as we work to provide the best care to a growing number of dialysis patients in St. Louis. We thank St. Luke's Episcopal-Presbyterian Hospitals and St. John's Mercy Health System for working with us over the last years to build a dialysis program that provides high quality care to our patients, as we look forward to building on that legacy with Ambulatory Services of America and Renal Services of America."

Timothy Martin, President and Chief Executive Officer of ASA, said, "We are pleased to welcome the physicians, patients and staff members to the ASA team. We believe Affiliated Hospitals Dialysis Center and its hospital partners built a solid program in St. Louis, and we look forward to working to build on their legacy to provide high quality services to dialysis patients in the St. Louis area."

Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians. ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Renal Services of America, Inc. owns, operates and manages facilities providing radiation oncology services and dialysis services. After the acquisition, ASA will own interests in and operate 44 dialysis centers and 13 radiation oncology centers in ten states and the territory of Guam. ASA also manages three other dialysis centers.


'/>"/>
SOURCE Ambulatory Services of America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Chicago-Area Radiation Oncology Facility
2. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas
3. Ambulatory Services of America, Inc. Announces Investment by Lindsay Goldberg
4. Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP
5. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
6. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
7. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
8. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
9. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
10. BPO Management Services Wins Two New Information Technology Outsourcing Contracts
11. Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017  Directors from Pharma To Market Pty Ltd and ... forces, resulting in the founding of Pharma To Market Pte Ltd, ... Market are pleased to announce their expansion into Asia ... Singapore . The company are delighted to appoint Joelle ... Singapore based entity. Joelle brings with her ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... Südkorea, 23. Februar 2017 LG Innotek hat ... vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der ... im Bereich zwischen 200 und 280 nm und eignet sich ... indem es ihre DNA zerstört. Das Produkt von LG ... ...
Breaking Medicine Technology: